MedTrace Logo

Kappa Opioid Receptor Imaging in Depression (KOR Depression)

NCT02236702 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2016-08-17

No results posted yet for this study

Summary

The purpose of this study is to use positron emission tomography (PET) imaging to measure the activity of the kappa opioid receptor (KOR) in the brains of depressed and non-depressed individuals.

Conditions

Interventions

OTHER

Positron Emission Tomography (PET) imaging

Positron Emission Tomography (PET) imaging

Sponsors & Collaborators

Principal Investigators

  • Charles Marmar, MD · NYU School of Medicine

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2015-03-31
Completion
2016-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02236702 on ClinicalTrials.gov